| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.0077 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |